Literature DB >> 2168676

Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation.

M Glassman1, A Spark, S Berezin, S Schwarz, M Medow, L J Newman.   

Abstract

Thirty-six children identified as having primary type IIa hypercholesterolemia were treated with a diet restricting the intake of saturated fat to 10% of total energy and supplemented with soluble fiber for 8.1 +/- 2.4 (mean +/- SEM) months. In 14 of 36 patients first treated with the American Heart Association "Step-One" diet for 8.0 +/- 1.1 months, total cholesterol level dropped from 257.9 +/- 15.8 mg/dL to 240.6 +/- 10.9 mg/dL; the low-density lipoprotein cholesterol level dropped from 191.8 +/- 17.4 mg/dL to 175.0 +/- 11.7 mg/dL; the high-density lipoprotein cholesterol level dropped from 42.8 +/- 1.94 mg/dL to 41.6 +/- 1.68 mg/dL; and triglyceride concentration rose from 115.9 +/- 13.7 mg/dL to 128.1 +/- 14.1 mg/dL. The 36 patients treated with saturated fat-restrictive diets and supplemental soluble fiber diets had a reduction of total cholesterol levels from 249.2 +/- 7.66 mg/dL to 207.1 +/- 6.31 mg/dL and a low-density lipoprotein cholesterol level reduction from 184.7 +/- 7.55 mg/dL to 142.6 +/- 6.7 mg/dL, a reduction of 18% and 23%, respectively. There was no significant change in high-density lipoprotein cholesterol levels (46.4 +/- 1.9 mg/dL vs 44.3 +/- 2.1 mg/dL) or in triglyceride concentrations (94.2 +/- 7.43 mg/dL vs 102.2 +/- 8.45 mg/dL). In addition, the reduction in serum lipoprotein concentrations resulting from this program was significantly greater than the concentrations resulting from the American Heart Association diet alone. The different responses to these regimens suggest that a simplified diet and soluble fiber supplementation is well tolerated and reduces total and low-density lipoprotein cholesterol levels more effectively than the standard American Heart Association diet in children.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168676     DOI: 10.1001/archpedi.1990.02150330033016

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  7 in total

Review 1.  Should pediatric patients with hyperlipidemia receive drug therapy?

Authors:  Deepak Bhatnagar
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Psyllium fibre and the metabolic control of obese children and adolescents.

Authors:  L A Moreno; B Tresaco; G Bueno; J Fleta; G Rodríguez; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2003-09       Impact factor: 4.158

3.  African-American mothers' perceptions of cholesterol and its effects on their children.

Authors:  J H Price; S M Casler
Journal:  J Natl Med Assoc       Date:  1996-03       Impact factor: 1.798

4.  Familial hypercholesterolemia and intracavernous venous spilling of cholesterol in a child with large suprasellar dermoid cyst. Case report.

Authors:  P Lunardi; P Missori
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

5.  Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trial.

Authors:  Martin de Bock; José G B Derraik; Christine M Brennan; Janene B Biggs; Greg C Smith; David Cameron-Smith; Clare R Wall; Wayne S Cutfield
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  The effect of psyllium supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Cain C T Clark; Mina Salek; Elahe Aghabagheri; Sadegh Jafarnejad
Journal:  Korean J Intern Med       Date:  2020-02-19       Impact factor: 2.884

Review 7.  Nutraceuticals in Paediatric Patients with Dyslipidaemia.

Authors:  Giuseppe Banderali; Maria Elena Capra; Claudia Viggiano; Giacomo Biasucci; Cristina Pederiva
Journal:  Nutrients       Date:  2022-01-27       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.